Immunoblot Method To Detect Streptococcus and Identify Multiple Serotypes from Nasopharyngeal Secretions
暂无分享,去创建一个
[1] E. Lewis,et al. Impact of the pneumococcal conjugate vaccine on otitis media , 2003, The Pediatric infectious disease journal.
[2] E. Lewis,et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia , 2002, The Pediatric infectious disease journal.
[3] S. Black,et al. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine , 2001, The Pediatric infectious disease journal.
[4] A. Takala,et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. , 2001, The Journal of infectious diseases.
[5] George M. Carlone,et al. Evaluation of a Medium (STGG) for Transport and Optimal Recovery of Streptococcus pneumoniae from Nasopharyngeal Secretions Collected during Field Studies , 2001, Journal of Clinical Microbiology.
[6] S. Lockhart,et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.
[7] R. Dagan,et al. LACK OF UTILITY OF SEROTYPING MULTIPLE COLONIES FOR DETECTION OF SIMULTANEOUS NASOPHARYNGEAL CARRIAGE OF DIFFERENT PNEUMOCOCCAL SEROTYPES , 2000, The Pediatric infectious disease journal.
[8] E. Lewis,et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.
[9] R. Huebner,et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.
[10] E. Shapiro,et al. Pneumococcal vaccines: history, current status, and future directions. , 1999, The American journal of medicine.
[11] S. Johnson,et al. Immunoreactivity of Five Monoclonal Antibodies against the 37-Kilodalton Common Cell Wall Protein (PsaA) ofStreptococcus pneumoniae , 1998, Clinical Diagnostic Laboratory Immunology.
[12] A. Schuchat,et al. Bacterial Meningitis in the United States in 1995 , 1997 .
[13] I. Jado,et al. Dot blot assay for the serotyping of pneumococci , 1997, Journal of clinical microbiology.
[14] P. Kolenbrander,et al. Nucleotide sequence of the Streptococcus gordonii PK488 coaggregation adhesin gene, scaA, and ATP-binding cassette , 1994, Infection and immunity.
[15] J. Gruber. Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study , 1985 .
[16] B. Gray,et al. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.
[17] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.
[18] G. Siber,et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] A. Tomasz. Streptococcus pneumoniae : molecular biology & mechanisms of disease , 2000 .
[20] B. Greenwood,et al. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. , 1999, Epidemiologic reviews.
[21] D. L. Klein. Pneumococcal disease and the role of conjugate vaccines. , 1999, Microbial drug resistance.
[22] J. Butler. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. , 1997, Microbial drug resistance.